Inventor · disambiguated record
Isan Chen
Also filed as: CHEN ISAN
10 granted patents·5 pending applications·61 citations·filing 2013–2023
89Inventor score
Top patents by PatentIndex Score
15 records- 0194US9340524B2Androgen receptor modulator and uses thereofARAGON PHARMACEUTICALS INC·Filed 2014·Granted May 17, 2016·25 cites·4 claims
- 0291US10052314B2Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancerARAGON PHARMACEUTICALS INC·Filed 2017·Granted Aug 21, 2018·8 cites·25 claims
- 0388US10799489B2Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancerARAGON PHARMACEUTICALS INC·Filed 2019·Granted Oct 13, 2020·4 cites·18 claims
- 0488US9884054B2Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancerARAGON PHARMACEUTICALS INC·Filed 2013·Granted Feb 6, 2018·8 cites·19 claims
- 0588US9675586B2Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancerGENENTECH INC·Filed 2014·Granted Jun 13, 2017·9 cites·11 claims
- 0686USRE49353EAnti-androgens for the treatment of non-metastatic castrate-resistant prostate cancerARAGON PHARMACEUTICALS INC·Filed 2020·Granted Jan 3, 2023·1 cites·55 claims
- 0786US10849888B2Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancerARAGON PHARMACEUTICALS INC·Filed 2018·Granted Dec 1, 2020·3 cites·15 claims
- 0886US10799488B2Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancerARAGON PHARMACEUTICALS INC·Filed 2019·Granted Oct 13, 2020·3 cites·19 claims
- 0983USRE50642EAnti-androgens for the treatment of non-metastatic castrate-resistant prostate cancerARAGON PHARMACEUTICALS INC·Filed 2022·Granted Oct 21, 2025·0 cites·56 claims
- 1072US2021000812A1Anti-Androgens For The Treatment Of Non-Metastatic Castrate-Resistant Prostate CancerARAGON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1165US2021177821A1Androgen Receptor Modulator And Uses ThereofARAGON PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1263US2024068004A1Cell-free methods of producing antibodies to intracellular targetsMBRACE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1363US2024010714A1Cell-free methods of recombinant antibody productionMBRACE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1457US10034860B2Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancerGENENTECH INC·Filed 2017·Granted Jul 31, 2018·0 cites·12 claims
- 1556US2016220548A1Androgen receptor modulator and uses thereofARAGON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Isan Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →